OpenCYP: An open source database exploring human variability in activities and frequencies of polymophisms for major cytochrome P-450 isoforms across world populations.


Journal

Toxicology letters
ISSN: 1879-3169
Titre abrégé: Toxicol Lett
Pays: Netherlands
ID NLM: 7709027

Informations de publication

Date de publication:
10 Oct 2021
Historique:
received: 31 03 2021
revised: 22 07 2021
accepted: 27 07 2021
pubmed: 6 8 2021
medline: 21 9 2021
entrez: 5 8 2021
Statut: ppublish

Résumé

The open source database "OpenCYP database" has been developed based on the results of extensive literature searches from the peer-reviewed literature. OpenCYP provides data on human variability on baseline of activities and polymophism frequencies for selected cytochrome P-450 isoforms (CYP1A2, CYP2A6, CYP2D6, CYP3A4/3A5 and CYP3A7) in healthy adult populations from world populations. CYP enzymatic activities were generally expressed as the metabolic ratio (MR) between an unchanged probe drug and its metabolite(s) in urine or plasma measured in healthy adults. Data on other age groups were very limited and fragmented, constituting an important data gap. Quantitative comparisons were often hampered by the different experimental conditions used. However, variability was quite limited for CYP1A2, using caffeine as a probe substrate, with a symmetrical distribution of metabolic activity values. For CYP3A4, human variability was dependent on the probe substrate itself with low variability when data considering the dextromethorphan/demethilathed metabolite MR were used and large variability when the urinary 6β-hydroxycortisol/cortisol ratio was used. The largest variability in CYP activity was shown for CYP2D6 activity, after oral dosing of dextromethorphan, for which genetic polymorphisms are well characterised and constitute a significant source of variability. It is foreseen that the OpenCYP database can contribute to promising tools to support the further development of QIVIVE and PBK models for human risk assessment of chemicals particularly when combined with information on isoform-specific content in cells using proteomic approaches.

Identifiants

pubmed: 34352333
pii: S0378-4274(21)00199-5
doi: 10.1016/j.toxlet.2021.07.019
pii:
doi:

Substances chimiques

Protein Isoforms 0
Cytochrome P-450 Enzyme System 9035-51-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-282

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Susanna Vichi (S)

Istituto Superiore di Sanità, Environment & Health Department, Viale Regina Elena 299, Roma, Italy. Electronic address: susanna.vichi@iss.it.

Franca Maria Buratti (FM)

Istituto Superiore di Sanità, Environment & Health Department, Viale Regina Elena 299, Roma, Italy.

Emma Di Consiglio (E)

Istituto Superiore di Sanità, Environment & Health Department, Viale Regina Elena 299, Roma, Italy.

Laura Turco (L)

Istituto Superiore di Sanità, Environment & Health Department, Viale Regina Elena 299, Roma, Italy.

Leonie S Lautz (L)

Risk Assessment Department, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 rue Pierre et Marie Curie, Maisons-Alfort, F-94701, France.

Keyvin Darney (K)

Risk Assessment Department, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 rue Pierre et Marie Curie, Maisons-Alfort, F-94701, France.

Jean-Lou Christian Michel Dorne (JCM)

European Food Safety Authority, Via Carlo Magno 1A, 43126, Parma, Italy.

Emanuela Testai (E)

Istituto Superiore di Sanità, Environment & Health Department, Viale Regina Elena 299, Roma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH